HIPPO HOLDINGS INC (HIPO) Fundamental Analysis & Valuation

NYSE:HIPO • US4335392027

Current stock price

25.65 USD
-0.41 (-1.57%)
At close:
25.65 USD
0 (0%)
After Hours:

This HIPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. HIPO Profitability Analysis

1.1 Basic Checks

  • HIPO had positive earnings in the past year.
  • HIPO had a negative operating cash flow in the past year.
  • HIPO had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HIPO reported negative operating cash flow in multiple years.
HIPO Yearly Net Income VS EBIT VS OCF VS FCFHIPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of HIPO (5.12%) is better than 78.38% of its industry peers.
  • The Return On Equity of HIPO (22.75%) is better than 87.84% of its industry peers.
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HIPO Yearly ROA, ROE, ROICHIPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 21.31%, HIPO belongs to the top of the industry, outperforming 85.14% of the companies in the same industry.
  • The Operating Margin and Gross Margin are not available for HIPO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 21.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIPO Yearly Profit, Operating, Gross MarginsHIPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HIPO Health Analysis

2.1 Basic Checks

  • HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for HIPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIPO Yearly Shares OutstandingHIPO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HIPO Yearly Total Debt VS Total AssetsHIPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • HIPO has an Altman-Z score of -0.40. This is a bad value and indicates that HIPO is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of -0.40, HIPO is doing good in the industry, outperforming 66.22% of the companies in the same industry.
  • A Debt/Equity ratio of 0.11 indicates that HIPO is not too dependend on debt financing.
  • HIPO has a better Debt to Equity ratio (0.11) than 75.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACC8.95%
HIPO Yearly LT Debt VS Equity VS FCFHIPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • HIPO has a Current Ratio of 3.79. This indicates that HIPO is financially healthy and has no problem in meeting its short term obligations.
  • HIPO has a Current ratio of 3.79. This is amongst the best in the industry. HIPO outperforms 93.92% of its industry peers.
  • HIPO has a Quick Ratio of 3.79. This indicates that HIPO is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.79, HIPO belongs to the best of the industry, outperforming 93.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
HIPO Yearly Current Assets VS Current LiabilitesHIPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. HIPO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 203.38% over the past year.
  • The Revenue has grown by 25.93% in the past year. This is a very strong growth!
  • HIPO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.46% yearly.
EPS 1Y (TTM)203.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.55%
Revenue 1Y (TTM)25.93%
Revenue growth 3Y57.6%
Revenue growth 5Y55.46%
Sales Q2Q%18.04%

3.2 Future

  • HIPO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.38% yearly.
  • Based on estimates for the next years, HIPO will show a very strong growth in Revenue. The Revenue will grow by 22.06% on average per year.
EPS Next Y-84.03%
EPS Next 2Y-33.6%
EPS Next 3Y30.38%
EPS Next 5YN/A
Revenue Next Year24.38%
Revenue Next 2Y23.81%
Revenue Next 3Y22.06%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIPO Yearly Revenue VS EstimatesHIPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
HIPO Yearly EPS VS EstimatesHIPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

2

4. HIPO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.99, which indicates a very decent valuation of HIPO.
  • The rest of the industry has a similar Price/Earnings ratio as HIPO.
  • Compared to an average S&P500 Price/Earnings ratio of 26.78, HIPO is valued rather cheaply.
  • The Price/Forward Earnings ratio is 75.07, which means the current valuation is very expensive for HIPO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HIPO indicates a rather expensive valuation: HIPO more expensive than 81.76% of the companies listed in the same industry.
  • HIPO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 11.99
Fwd PE 75.07
HIPO Price Earnings VS Forward Price EarningsHIPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HIPO Per share dataHIPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HIPO's earnings are expected to grow with 30.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.6%
EPS Next 3Y30.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIPO Dividend Analysis

5.1 Amount

  • No dividends for HIPO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIPO Fundamentals: All Metrics, Ratios and Statistics

HIPPO HOLDINGS INC

NYSE:HIPO (4/10/2026, 8:29:00 PM)

After market: 25.65 0 (0%)

25.65

-0.41 (-1.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-25
Earnings (Next)05-07
Inst Owners48.24%
Inst Owner Change0%
Ins Owners10.97%
Ins Owner Change1.99%
Market Cap666.13M
Revenue(TTM)468.60M
Net Income(TTM)95.90M
Analysts80
Price Target39.44 (53.76%)
Short Float %2.63%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.4%
Min EPS beat(2)89.54%
Max EPS beat(2)107.26%
EPS beat(4)3
Avg EPS beat(4)215.38%
Min EPS beat(4)-18.4%
Max EPS beat(4)683.12%
EPS beat(8)6
Avg EPS beat(8)113.05%
EPS beat(12)7
Avg EPS beat(12)69.89%
EPS beat(16)7
Avg EPS beat(16)40.05%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)1.08%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)3.95%
Revenue beat(12)8
Avg Revenue beat(12)4.79%
Revenue beat(16)9
Avg Revenue beat(16)3.48%
PT rev (1m)-2.52%
PT rev (3m)-2.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)246.54%
EPS NY rev (3m)9960.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)5.53%
Valuation
Industry RankSector Rank
PE 11.99
Fwd PE 75.07
P/S 1.48
P/FCF N/A
P/OCF N/A
P/B 1.58
P/tB 1.83
EV/EBITDA N/A
EPS(TTM)2.14
EY8.34%
EPS(NY)0.34
Fwd EY1.33%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS17.33
BVpS16.23
TBVpS14.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number27.96
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.31%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.9%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z -0.4
F-Score6
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)117.59%
Cap/Depr(5y)128.11%
Cap/Sales(3y)9.44%
Cap/Sales(5y)12.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)203.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.55%
EPS Next Y-84.03%
EPS Next 2Y-33.6%
EPS Next 3Y30.38%
EPS Next 5YN/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y57.6%
Revenue growth 5Y55.46%
Sales Q2Q%18.04%
Revenue Next Year24.38%
Revenue Next 2Y23.81%
Revenue Next 3Y22.06%
Revenue Next 5YN/A
EBIT growth 1Y72.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.68%
EBIT Next 3Y64.73%
EBIT Next 5YN/A
FCF growth 1Y-19.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.41%
OCF growth 3YN/A
OCF growth 5YN/A

HIPPO HOLDINGS INC / HIPO Fundamental Analysis FAQ

What is the fundamental rating for HIPO stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIPO.


What is the valuation status for HIPO stock?

ChartMill assigns a valuation rating of 2 / 10 to HIPPO HOLDINGS INC (HIPO). This can be considered as Overvalued.


How profitable is HIPPO HOLDINGS INC (HIPO) stock?

HIPPO HOLDINGS INC (HIPO) has a profitability rating of 3 / 10.


How financially healthy is HIPPO HOLDINGS INC?

The financial health rating of HIPPO HOLDINGS INC (HIPO) is 5 / 10.